Drug researchers get their own networking site

Here's something to pass on to the scientists in your life. Over the past few years social networking sites have drawn in millions of people with the promise of instantaneous links to new and old circles of friends. Now the NIH is putting up $27 million to see if the same technology that connects teens and spurs plans for Saturday night can virally link a generation of biomedical researchers. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.